EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.7.1.40 | 5'-nucleotidase deficiency |
2491542 |
[Hemolytic anemias caused by erythrocyte enzyme disorders] |
causal interaction
unassigned |
4
0 |
| 2.7.1.40 | 5'-nucleotidase deficiency |
15142658 |
A basis of the acanthocytosis in inherited and acquired disorders. |
causal interaction
unassigned |
2
0 |
| 2.7.1.40 | 6-phosphofructokinase deficiency |
6225942 |
Kinetic properties of mutant enzymes in erythrocyte phosphofructokinase deficiency and erythrocyte pyruvate kinase deficiency. |
causal interaction
unassigned |
2
0 |
| 2.7.1.40 | Acute Kidney Injury |
26977258 |
Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 2.7.1.40 | Acute Kidney Injury |
34160104 |
Pyruvate kinase M2 mediates fibroblast proliferation to promote tubular epithelial cell survival in acute kidney injury. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
3
0 |
| 2.7.1.40 | Adenocarcinoma |
640321 |
Deviation of isozyme pattern of pyruvate kinase in the liver of nude mice bearing allogeneic or xenogeneic tumor. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
3
1
0 |
| 2.7.1.40 | Adenocarcinoma |
1708618 |
[Immunohistologic photometric quantification of pyruvate kinase content of rat tumors] |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
2
0 |
| 2.7.1.40 | Adenocarcinoma |
9160433 |
Changes in glucose transport activities in mammary adenocarcinoma of dogs. |
causal interaction
unassigned |
1
0 |
| 2.7.1.40 | Adenocarcinoma |
12820320 |
Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
4
1
1
0 |
| 2.7.1.40 | Adenocarcinoma |
15509675 |
The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
3 |
